Article Details
Retrieved on: 2019-07-21 23:21:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Opaleye Management <b>Inc</b> increased its stake in Ptc Therapeutics <b>Inc</b> (PTCT) by 12.53% based on its latest 2019Q1 regulatory filing with the SEC.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here